Organovo Logo     Print Page | Close Window

Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the preclinical safety, efficacy and disease modeling and therapeutic tissues markets
2016 Annual Report Investor Fact Sheet Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$3.01
Change (%)0.00 (0.00%)
Volume0
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $3.01 with a 52 week high of $4.99 and a 52 week low of $2.01.
Recent Investor News
03/13/17
Organovo and Its Customers Present Data Supporting 3D Bioprinted Liver and Kidney Tissues for Drug Toxicity Testing
03/09/17
Organovo to Present at 29th Annual Roth Conference
Investor Events
There are currently no events scheduled.
Featured Reports
2016 Annual Report
2016 Proxy Statement
Latest Tweets